ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alaska » Internal Medicine

Top Internal Medicine Prescribers in Alaska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LOETTA HORSWILL-WOODS DO

Internal Medicine

9,283

$801K

200
124 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 30%

$86
Average prescription price

Avg: $76

ANDREA GREENFELD MD

Internal Medicine

7,476

$498K

307
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$67
Average prescription price

Avg: $76

LINDA WERNER MD

Internal Medicine

6,679

$339K

448
392 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 30%

$51
Average prescription price

Avg: $76

BRUCE STOCKHOUSE MD

Internal Medicine

5,995

$147K

99
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 30%

$25
Average prescription price

Avg: $76

LISA COONEY MD

Internal Medicine

5,388

$416K

204
161 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 30%

$77
Average prescription price

Avg: $76

JOHN BRAMANTE MD

Internal Medicine

5,264

$370K

285
230 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$70
Average prescription price

Avg: $76

WILLIAM ANTHES MD

Internal Medicine

5,083

$346K

147
123 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$68
Average prescription price

Avg: $76

JEFFREY MCDONALD

Internal Medicine

4,721

$328K

207
173 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$70
Average prescription price

Avg: $76

JOHN BOSTON D.O.

Internal Medicine

4,444

$265K

264
179 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$60
Average prescription price

Avg: $76

NATALIE BEYELER D.O.

Internal Medicine

4,159

$358K

137
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 30%

$86
Average prescription price

Avg: $76

SUSAN HEVERLING M.D.

Internal Medicine

4,116

$355K

80
57 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 30%

$86
Average prescription price

Avg: $76

WILLIAM KELLEY MD

Internal Medicine

3,962

$393K

309
233 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 30%

$99
Average prescription price

Avg: $76

WILLIAM RAGLE MD

Internal Medicine

3,921

$332K

178
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 30%

$85
Average prescription price

Avg: $76

JOHN HUNTER M.D.

Internal Medicine

3,593

$309K

95
73 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 30%

$86
Average prescription price

Avg: $76

DIRK CRAFT DO

Internal Medicine

3,472

$363K

69
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 30%

$105
Average prescription price

Avg: $76

DAVID BARNES D.O.

Internal Medicine

3,369

$359K

115
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 30%

$107
Average prescription price

Avg: $76

CHERYL COLLIER-BROWN MD

Internal Medicine

3,349

$222K

214
150 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$66
Average prescription price

Avg: $76

MARY SCHUMACHER MD

Internal Medicine

3,346

$219K

218
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 30%

$66
Average prescription price

Avg: $76

NELL LOFTIN M.D.

Internal Medicine

3,258

$182K

141
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$56
Average prescription price

Avg: $76

MOAZZEM KHAN M.D.

Internal Medicine

3,147

$231K

226
101 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 30%

$74
Average prescription price

Avg: $76

ELIZABETH FUNK M.D., MPH

Internal Medicine

3,029

$207K

198
165 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 30%

$69
Average prescription price

Avg: $76

MICHAEL SWENSON M.D.

Internal Medicine

3,009

$337K

146
99 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$112
Average prescription price

Avg: $76

PETER RICE MD

Internal Medicine

2,924

$195K

188
147 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$67
Average prescription price

Avg: $76

GEORGE SPADY MD

Internal Medicine

2,903

$256K

268
210 are 65+

20%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$88
Average prescription price

Avg: $76

JULIE MCCORMICK M.D.

Internal Medicine

2,802

$210K

93
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$75
Average prescription price

Avg: $76

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank